ADROPIN

/ SCIENCE / By
  1. ADROPIN is a novel regulator of endothelial function
  2. A novel peptide ADROPIN in cardiovascular diseases
  3. ADROPIN as a fat-burning hormone with multiple functions—Review of a decade of research
  4. Serum ADROPIN levels are decreased in patients with acute myocardial infarction
  5. ADROPIN deficiency is associated with increased adiposity and insulin resistance
  6. Three new players in energy regulation: preptin, ADROPIN and irisin
  7. Elevated plasma levels of ADROPIN in heart failure patients
  8. ADROPIN -physiological and pathophysiological role.
  9. Maternal and fetal ADROPIN levels in gestational diabetes mellitus
  10. Low serum ADROPIN is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients
  11. Regulation of substrate oxidation preferences in muscle by the peptide hormone ADROPIN
  12. Identification of ADROPIN as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism
  13. Therapeutic effects of ADROPIN on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance
  14. ADROPIN is associated with hyperhomocysteine and coronary atherosclerosis
  15. Deficiency of a new protein associated with cardiac syndrome X; called ADROPIN
  16. Inverse correlation between plasma ADROPIN and ET-1 levels in essential hypertension: A cross-sectional study
  17. Serum ADROPIN level in patients with stable coronary artery disease
  18. ADROPIN regulates cardiac energy metabolism and improves cardiac function and efficiency
  19. Serum ADROPIN levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index
  20. Low circulating ADROPIN concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans
  21. ADROPIN : An endocrine link between the biological clock and cholesterol homeostasis
  22. Association of serum ADROPIN concentrations with diabetic nephropathy
  23. Correlation of serum ADROPIN level with coronary artery disease
  24. A review of ADROPIN as the medium of dialogue between energy regulation and immune regulation
  25. Metabolic syndrome patients have lower levels of ADROPIN when compared with healthy overweight/obese and lean subjects
  26. Evaluation of the relationship between serum ADROPIN levels and blood pressure in obese children
  27. ADROPIN deficiency worsens HFD-induced metabolic defects
  28. ADROPIN correlates with aging-related neuropathology in humans and improves cognitive function in aging mice
  29. Serum ADROPIN levels are reduced in patients with inflammatory bowel diseases
  30. Circulating ADROPIN concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function
  31. Plasma ADROPIN levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus
  32. A novel biomarker in patients with knee osteoarthritis: ADROPIN
  33. Aerobic exercise training-induced changes in serum ADROPIN level are associated with reduced arterial stiffness in middle-aged and older adults
  34. ADROPIN : a hepatokine modulator of vascular function and cardiac fuel metabolism
  35. Investigation of ADROPIN and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease
  36. The effect of ADROPIN on lipid and glucose metabolism in rats with hyperlipidemia
  37. ADROPIN as a potential mediator of the metabolic system‐autonomic nervous system‐chronobiology axis: Implementing a personalized signature‐based platform for …
  38. Inverse association between carbohydrate consumption and plasma ADROPIN concentrations in humans
  39. Effects of ADROPIN on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes
  40. Association between serum ADROPIN levels and gestational diabetes mellitus; a case–control study
  41. ADROPIN Serum Levels in Patients with Primary Sjögren’s Syndrome
  42. ADROPIN and apelin fluctuations throughout a season in professional soccer players: Are they related with performance?
  43. ADROPIN protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity
  44. Fasting plasma ADROPIN concentrations correlate with fat consumption in human females
  45. ADROPIN -a novel biomarker of heart disease: a systematic review article
  46. Association between aerobic exercise training effects of serum ADROPIN level, arterial stiffness, and adiposity in obese elderly adults
  47. Expression of ADROPIN in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes
  48. ADROPIN and irisin in arterial hypertension, diabetes mellitus and chronic kidney disease.
  49. Role of ADROPIN in Cardiometabolic Disorders: From Pathophysiological Mechanisms to Therapeutic Target
  50. ADROPIN reduces blood glucose levels in mice by limiting hepatic glucose production
  51. Aerobic Exercise Restores Aging‐Associated Reductions in Arterial ADROPIN Levels and Improves ADROPIN ‐Induced Nitric Oxide‐Dependent Vasorelaxation
  52. ADROPIN is a brain membrane-bound protein regulating physical activity via the NB-3/Notch signaling pathway in mice
  53. ADROPIN levels and target organ damage secondary to high blood pressure in the ED
  54. ADROPIN treatment restores cardiac glucose oxidation in pre-diabetic obese mice
  55. ADROPIN and inflammation biomarker levels in male patients with obstructive sleep apnea: a link with glucose metabolism and sleep parameters
  56. Elevated ADROPIN : a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I
  57. Serum ADROPIN levels are reduced in adult patients with nonalcoholic fatty liver disease
  58. A possible connection between tumor necrosis factor alpha and ADROPIN levels in polycystic ovary syndrome
  59. Copeptin, ADROPIN and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus
  60. ADROPIN acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19
  61. Immunohistochemical expressions of ADROPIN and ınducible nitric oxide synthase in renal tissues of rats with streptozotocin-ınduced experimental diabetes
  62. ADROPIN contributes to anti-atherosclerosis by suppressing monocyte-endothelial cell adhesion and smooth muscle cell proliferation
  63. Hepatocyte expression of the micropeptide ADROPIN regulates the liver fasting response and is enhanced by caloric restriction
  64. ADROPIN : a key component and potential gatekeeper of metabolic disturbances in policystic ovarian syndrome
  65. ADROPIN in immune and energy balance:’a molecule of interest’in male reproduction
  66. Aerobic exercise improves endothelial function and serum ADROPIN levels in obese adolescents independent of body weight loss
  67. Age-dependent decrease in ADROPIN is associated with reduced levels of endothelial nitric oxide synthase and increased oxidative stress in the rat brain
  68. The peptide hormone ADROPIN regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity
  69. Low plasma ADROPIN concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates
  70. Serum ADROPIN Levels in Patients on Hemodialysis
  71. ADROPIN -based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction
  72. ADROPIN as an indicator of T2DM and its complications
  73. ADROPIN and irisin in patients with cardiac cachexia
  74. ADROPIN and insulin resistance: Integration of endocrine, circadian, and stress signals regulating glucose metabolism
  75. Differential responses of plasma ADROPIN concentrations to dietary glucose or fructose consumption in humans
  76. ADROPIN : a new marker for predicting late saphenous vein graft disease after coronary artery bypass grafting
  77. Assessment of serum concentrations of ADROPIN , afamin, and neudesin in children with type 1 diabetes
  78. The glycosyltransferase EOGT regulates ADROPIN expression in decidualizing human endometrium
  79. ADROPIN regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway
  80. Lower ADROPIN expression is associated with oxidative stress and severity of nonalcoholic fatty liver disease
  81. ADROPIN as a novel energy factor likely has the ability to regulate blood pressure
  82. Serum ADROPIN Levels in Patients with Rheumatoid Arthritis
  83. ADROPIN reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions
  84. Salusins and ADROPIN : new peptides potentially involved in lipid metabolism and atherosclerosis
  85. Potential roles of ADROPIN in central nervous system: review of current literature
  86. ADROPIN as a potential marker of enzyme-positive acute coronary syndrome
  87. Inflammatory response and matrix metalloproteinases in chronic kidney failure: Modulation by ADROPIN and spexin
  88. Changes in plasma C1q, apelin and ADROPIN concentrations in older adults after descending and ascending stair walking intervention
  89. The impact of serum ADROPIN and ischemia modified albumin levels based on BMI in PCOS
  90. Relationship between human cord blood ADROPIN levels and fetal growth
  91. ADROPIN stimulates proliferation but suppresses differentiation in rat primary brown preadipocytes
  92. ADROPIN regulates hepatic glucose production via PP2A/AMPK pathway in insulin‐resistant hepatocytes
  93. Association between ADROPIN and coronary artery lesions in children with Kawasaki disease
  94. The association of serum and vitreous ADROPIN concentrations with diabetic retinopathy
  95. ADROPIN induction of lipoprotein lipase expression in tilapia hepatocytes
  96. ADROPIN preserves the blood‐brain barrier through a Notch1/Hes1 pathway after intracerebral hemorrhage in mice
  97. Acute and chronic effects of aerobic exercise on serum irisin, ADROPIN , and cholesterol levels in the winter season: Indoor training versus outdoor training
  98. ADROPIN reduces hypoxia/reoxygenation‑induced myocardial injury via the reperfusion injury salvage kinase pathway
  99. Relationship between plasma ADROPIN levels and body composition and lipid characteristics amongst young adolescents in Taiwan
  100. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of ADROPIN
  101. Vasodilatory function in human skeletal muscle feed arteries with advancing age: the role of ADROPIN
  102. ADROPIN stimulates proliferation and inhibits adrenocortical steroidogenesis in the human adrenal carcinoma (HAC15) Cell Line
  103. Alterations of irisin, ADROPIN , preptin and BDNF concentrations in coronary heart disease patients comorbid with depression
  104. Enho mutations causing low ADROPIN : a possible pathomechanism of MPO-ANCA associated lung injury
  105. Correlation between circulating ADROPIN levels and patients with PCOS: An updated systematic review and meta-analysis
  106. Effects of chronic and intermittent calorie restriction on ADROPIN levels in breast cancer
  107. Low concentrations of ADROPIN are associated with endothelial dysfunction as assessed by flow-mediated dilatation in patients with metabolic syndrome
  108. Negative association between serum ADROPIN and hypertensive disorders complicating pregnancy
  109. Plasma ADROPIN as a potential marker predicting obesity and obesity-associated cancer in Korean patients with type 2 diabetes mellitus
  110. First and third trimester serum concentrations of ADROPIN and copeptin in gestational diabetes mellitus and normal pregnancy
  111. Serum irisin, ADROPIN , and preptin in obese patients 6 months after bariatric surgery
  112. Neuroprotective effect of ischemic preconditioning via modulating the expression of ADROPIN and oxidative markers against transient cerebral ischemia in diabetic rats
  113. Association between serum ADROPIN level and coronary artery disease: a systematic review and meta-analysis
  114. ADROPIN levels and its associations as a fat-burning hormone in patients with polycystic ovary syndrome: a correlational meta-analysis
  115. Serum ADROPIN levels in psoriasis vulgaris and its relation with metabolic parameters
  116. Are obesity and metabolic syndrome associated with plasma ADROPIN levels in children?
  117. ADROPIN and circadian variation of blood pressure
  118. Serum ADROPIN level is associated with endothelial dysfunction in patients with obstructive sleep apnea and hypopnea syndrome
  119. Circulating ADROPIN levels in patients with endometrium cancer
  120. Association between serum ADROPIN level and burden of coronary artery disease in patients with non-ST elevation myocardial infarction
  121. Maternal ADROPIN levels in patients with gestational diabetes mellitus: A systematic review and meta-analysis
  122. Low serum ADROPIN levels are associated with coronary slow flow phenomenon
  123. Neurovascular protection by ADROPIN in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism
  124. Effect of long-term continuous light exposure and western diet on ADROPIN expression, lipid metabolism, and energy homeostasis in rats
  125. ADROPIN –Potential Link in Cardiovascular Protection for Obese Male Type 2 Diabetes Mellitus Patients Treated with Liraglutide
  126. Presence of ADROPIN , nesfatin-1, apelin-12, ghrelins and salusins peptides in the milk, cheese whey and plasma of dairy cows
  127. ADROPIN levels in polycystic ovary syndrome patients
  128. ADROPIN decreases endothelial monolayer permeability after cell-free hemoglobin exposure and reduces MCP-1-induced macrophage transmigration
  129. Serum ADROPIN level and ENHO gene expression in systemic sclerosis
  130. Effect of aerobic exercise with maximal fat oxidation intensity, on ADROPIN and insulin resistance among overweight women
  131. Involvement of ADROPIN and ADROPIN -associated genes in metabolic abnormalities of hemodialysis patients
  132. Promotion of ADROPIN expression by hyperglycemia is associated with STAT3 activation in diabetic rats
  133. Exercise in the cold causes greater irisin release but may not be enough for ADROPIN
  134. Adipokine, ADROPIN and endothelin-1 levels in intrauterine growth restricted neonates and their mothers
  135. Serum ADROPIN as a predictive biomarker of erectile dysfunction in coronary artery disease patients
  136. ADROPIN and glucagon-like peptide-2 are associated with glucose metabolism in obese children
  137. Role of serum ADROPIN measurement in the assessment of insulin resistance in obesity
  138. ADROPIN Slightly Modulates Lipolysis, Lipogenesis and Expression of Adipokines but Not Glucose Uptake in Rodent Adipocytes
  139. ADROPIN transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice
  140. ADROPIN in women with polycystic ovary syndrome
  141. ADROPIN levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles
  142. Effects of ADROPIN on learning and memory in rats tested in the Morris water maze
  143. Hepatic ADROPIN is regulated by estrogen and contributes to adverse metabolic phenotypes in ovariectomized mice
  144. Role of rs7903146 polymorphism and ADROPIN serum level in patients with diabetes mellitus; a case–control study from Isfahan, Iran
  145. Obestatin and ADROPIN in Prader‐Willi syndrome and nonsyndromic obesity: Associations with weight, BMI‐z, and HOMA‐IR
  146. ADROPIN acts in the rat paraventricular nucleus to influence neuronal excitability
  147. ADROPIN inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation
  148. ENHO gene expression and serum ADROPIN level in rheumatoid arthritis and systemic lupus erythematosus
  149. Association of serum ADROPIN with the presence of atrial fibrillation and atrial remodeling
  150. The Clinical Value of Serum ADROPIN Level in Early Detection of Diabetic Nephropathy
  151. Alteration of serum and cardiac tissue ADROPIN , copeptin, irisin and TRPM2 expressions in DOX treated male rats
  152. The changing features of serum ADROPIN , copeptin, neprilysin and chitotriosidase which are associated with vascular endothelial function in type 2 diabetic retinopathy …
  153. The effect of eight weeks of resistance training on ADROPIN plasma level and insulin resistance index in overweight men
  154. Effects of eight weeks exercise training on serum levels of ADROPIN in male volleyball players
  155. Association between serum ADROPIN levels and isolated coronary artery ectasia in patients with stable angina pectoris
  156. Alterations in serum ADROPIN , adiponectin, and proinflammatory cytokine levels in OSAS
  157. Novel associations of serum ADROPIN and lipopolysaccharide-binding protein versus lipid profiles in childhood obesity
  158. Opposite association of ADROPIN concentrations with obesity in prepubertal children compared with adolescents
  159. Association of polymorphisms of preptin, irisin and ADROPIN genes with susceptibility to coronary artery disease and hypertension
  160. Elevated serum levels of ADROPIN in patients with type 2 diabetes mellitus and its association with insulin resistance
  161. Differential circulating concentrations of adipokines, glucagon and ADROPIN in a clinical population of lean, overweight and diabetic cats
  162. Unique novel role of ADROPIN in a gastric ulcer in a rotenone-induced rat model of Parkinson’s disease
  163. Role of swimming on muscle PGC-1α, FNDC5 mRNA, and assessment of serum omentin, ADROPIN , and irisin in high carbohydrate high fat (HCHF) diet …
  164. The Effect of 8 Weeks of Combined Training on Serum ADROPIN and Nitric Oxide in Hypertensive Postmenopausal Women
  165. ADROPIN concentrations in term pregnancies with normal, restricted and increased fetal growth
  166. ADROPIN and spexin hormones regulate the systemic inflammation in adenine-induced chronic kidney failure in rat
  167. Circulating levels of ADROPIN and overweight/obesity: a systematic review and meta-analysis of observational studies
  168. Protective effect of ADROPIN against high fat diet-induced obese diabetic wistar rats via nuclear factor erythroid 2-related factor 2 pathway
  169. The association between serum ADROPIN and carotid atherosclerosis in patients with type 2 diabetes mellitus: a cross‑sectional study
  170. The effect of thyroid dysfunction and treatment on ADROPIN , asprosin and preptin levels in rats
  171. Evaluation of serum ADROPIN and irisin levels and its association with anthropometric obesity indices and biochemical parameters in Type 2 diabetic patients
  172. ADROPIN and irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study
  173. Alteration of serum ADROPIN level in preeclampsia
  174. ADROPIN Improves Radiation-Induced Myocardial Injury via VEGFR2/PI3K/Akt Pathway
  175. Serum ADROPIN as a Potential Biomarker for Predicting the Development of Type 2 Diabetes Mellitus in Individuals With Metabolic Dysfunction-Associated …
  176. ADROPIN and apelin‐12 efficiently predict metabolic syndrome in obese children
  177. Myricetin Increases Circulating ADROPIN Level after Activation of Glucagon-like Peptide 1 (GLP-1) Receptor in Type-1 Diabetic Rats
  178. Improved blood pressure and flow‐mediated dilation via increased plasma ADROPIN and NOx induced by high‐intensity interval training in patients with type 2 diabetes
  179. Are ADROPIN , apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?
  180. The Effect of Aerobic water-based training on ADROPIN levels, insulin resistance and Lipid profile in ageing Men
  181. LncRNA HDAC11-AS1 Suppresses Atherosclerosis by Inhibiting HDAC11-Mediated ADROPIN Histone Deacetylation
  182. Short-term circuit resistance training improves insulin resistance probably via increasing circulating ADROPIN
  183. The role of ADROPIN , HIF-1α and apelin biomarkers in the diagnosis of acute mesentaric ischemia
  184. ADROPIN –a circulating factor in metabolic control or a drop in the ocean?
  185. ADROPIN is a key mediator of hypoxia induced anti-dipsogenic effects via TRPV4-CamKK-AMPK signaling in the circumventricular organs of rats
  186. Preptin and ADROPIN levels as new predictor in women with polycystic ovary syndrome
  187. The relationship between maternal and umbilical cord ADROPIN levels with the presence and severity of preeclampsia
  188. Investigation of blood leptin and ADROPIN levels in patients with multiple sclerosis: A CONSORT-clinical study
  189. Afamin and ADROPIN in patients with alcohol-induced liver cirrhosis
  190. Investigation of serum ADROPIN levels and its relationship with hypothalamic atrophy in patients with multiple sclerosis
  191. Role of serum ADROPIN as a novel biomarker in primary knee osteoarthritis patients: Relation to the functional status, radiographic grading and …
  192. Serum irisin and ADROPIN levels may be predictors for coronary artery ectasia
  193. Pentraxin-3 and ADROPIN as inflammatory markers of early renal damage in type 2 diabetes patients
  194. Two weeks of moderate intensity locomotor training increased corticosterone concentrations but did not alter the number of ADROPIN -immunoreactive cells in the …
  195. ADROPIN Alleviates Myocardial Fibrosis in Diabetic Cardiomyopathy Rats: A Preliminary Study
  196. Anti-diabetic Role of ADROPIN in Streptozotocin Induced Diabetic Rats via Alteration of PI3K/Akt and Insulin Signaling Pathway
  197. Molecular cloning and characterization of the novel ADROPIN from tilapia (Oreochromis niloticus): Involvement in the control of food intake
  198. Effects of probiotic yogurt on serum omentin-1, ADROPIN , and nesfatin-1 concentrations in overweight and obese participants under low-calorie diet
  199. ADROPIN suppresses insulin expression and secretion in INS-1E cells and rat pancreatic islets
  200. ADROPIN confers neuroprotection and promotes functional recovery from ischemic stroke
  201. Potential effects of ADROPIN on systemic metabolic and hormonal abnormalities in polycystic ovary syndrome
  202. Plasma ADROPIN level in patients with pseudoexfoliation
  203. Correlation of Serum ADROPIN Levels with Risk Factors of Cardiovascular Disease in Hemodialysis Patients
  204. Abstract TP277: ADROPIN is Profoundly Neuroprotective in Experimental Ischemic Stroke
  205. Diet-induced obese mice are resistant to improvements in cardiac function resulting from short-term ADROPIN treatment
  206. ADROPIN expression correlates with age-related neuropathologies in the human brain and improves neuroin ammation and cognitive function in aging mice
  207. Serum ADROPIN levels in a preeclampsia like L-name rat model treated with sildenafil citrate
  208. Role of ADROPIN in cardiovascular physiology
  209. Identification of a Candidate ADROPIN Receptor
  210. ADROPIN influence on nephropathy development in hypertensive patients associated with diabetes mellitus 2 type
  211. Effects of prepartum fat supplementation on plasma concentrations of glucagon-like peptide-1, peptide YY, ADROPIN , insulin, and leptin in periparturient dairy …
  212. ADROPIN in pregnancy complicated by hyperglycemia and obesity—a preliminary study
  213. Comparison of Serum ADROPIN Levels in Patients with Diabetes Mellitus, COVID-19, and COVID-19 with Diabetes Mellitus.
  214. Effect of aerobic exercise and caloric restriction on serum ADROPIN levels and homa-ir in obese sedentary women
  215. Circulating ADROPIN and vascular endothelial growth factor receptor-2 levels in age-related macular degeneration and T2DM patients—A cross-sectional study
  216. Exposure to ADROPIN improves insulin-induced dilation in arteries from type 2 diabetic mice
  217. Serum ADROPIN Level Correlation with Blood Pressure: A case-control study
  218. The relationship between ADROPIN levels and the slow coronary flow phenomenon
  219. Tilapia ADROPIN : the localization and regulation of growth hormone gene expression in pituitary cells
  220. ADROPIN : connection between nonalcoholic fatty liver disease and coronary artery disease
  221. Serum ADROPIN and nitric oxide levels in missed abortus cases
  222. Investigation of the irisin, preptin and ADROPIN levels in the blood serum of Alburnus tarichi
  223. Comparative analysis of ADROPIN concentration changes in response to kidney transplantation
  224. Postprandial ADROPIN responses in women co-ingesting green leafy vegetables with a carbohydrate meal: interactions with the sirtuin system
  225. Effect of Peri-Implant Disease on ADROPIN Levels: A Cross-Sectional Pilot Study
  226. Optimal therapeutic ADROPIN dose intervention in mice and rat animal models: A systematic review
  227. Estimation of Lepitn, Melatonin, and ADROPIN Hormones in Gestational Diabetes Mellitus (GDM) in Tikrit City.
  228. POS0477 ATTENUATION OF FIBROBLAST ACTIVATION AND FIBROSIS BY ADROPIN IN A HEDGEHOG-DEPENDENT MANNER
  229. Increased risk of cognitive impairment and hyperglycemia-related mortality in late middle-aged African Americans with low serum ADROPIN levels
  230. The Correlation between the Serum Level of ADROPIN and Blood Pressure: A Case-Control Study.
  231. ADROPIN inhibits the phenotypic modulation and proliferation of vascular smooth muscle cells during neointimal hyperplasia by activating the AMPK/ACC …
  232. Effects of Carnosine and Vitamin E on Nucleobindin 2 (NUCB2)/nesfatin-1, Ghrelin, ADROPIN , and Irisin in Experimentally Induced Ovarian Torsion
  233. ADROPIN is a Novel Regulator of Endothelial Function Through the VEGFR2-PI3K-Akt and VEGFR2-Erk1/2 Pathways
  234. Immunohistochemical localization of ADROPIN in the small intestine of rats
  235. The Effect of Combined Training and L-arginine Supplement on the Serum Levels of ADROPIN , VEGFR-2, and Nitric Oxide in Post-menopausal Hypertensive Women
  236. The Effect of Aerobic Training on Preptin, ADROPIN and Insulin Resistance in Overweight Men
  237. The role of ADROPIN , salusin-α, netrin-1, and nesfatin-1 in endometriosis and their association with insulin resistance
  238. Serum ADROPIN level and kidney functions in Type-II diabetic rat model with and without pioglitazone treatment
  239. Microalbuminuria by concentration serum and urine levels of ADROPIN in patients with type 2 diabetes mellitus
  240. Serum vascular endothelial growth factor receptor-2 and ADROPIN levels in age-related macular degeneration
  241. The Hepatokine ADROPIN Is Regulated by Estrogen
  242. Abstract WP315: Neuroprotective Effects of Endogenous ADROPIN in Experimental Ischemic Stroke
  243. Evaluation of serum ADROPIN levels in type 2 diabetic patients and its correlation with insulin resistance: A tertiary care teaching hospital-based study
  244. Evaluation of cardiometabolic function with serum ADROPIN levels in psoriasis patients
  245. Decreased Plasma ADROPIN : A Possible Risk Factor for Metabolic Syndrome in Type 2 Diabetic Patients in South-West, Nigeria
  246. ADROPIN levels in dipper and non-dipper hypertensive patients depending on the presence of diabetes mellitus 2 type and obesity
  247. Serum ADROPIN : Pathogenesis and Clinical Research in Cardiovascular Disease.
  248. Elevation of arterial ADROPIN secretion by aerobic exercise training is related to vasodilation via increase in nitric oxide production in aged mice
  249. Effects of High-Intensity Interval Training on ADROPIN , Blood Glucose Markers, Insulin Resistance
  250. ADROPIN IN PATIENTS WITH HEART FAILURE
  251. … of 8 weeks of combined interval (resistance-interval training) and combined endurance (endurance-resistance training) on plasma levels of ADROPIN and nitric oxide in …
  252. ADROPIN and Irisin in Patients with Cardiac Cachexia
  253. ADROPIN and irisin levels in a rat model of hypothyroidism
  254. The effectiveness of serum S100B, TRAIL, and ADROPIN levels in predicting clinical outcome, final infarct core, and stroke subtypes of acute ischemic stroke patients
  255. Current Knowledge of Selected Cardiovascular Biomarkers in Pediatrics: Kidney Injury Molecule-1, Salusin-α and-β, Uromodulin, and ADROPIN
  256. Regulation of ADROPIN by Sitagliptin Monotherapy in Participants With Newly Diagnosed Type 2 Diabetes
  257. Characterizing the Therapeutic Potential of the ADROPIN ‐GPR19 Signaling Pathway in MAFLD
  258. Plasma ADROPIN levels are associated with lipid characteristics amongst children with obesity
  259. Assessment of serum ADROPIN level in type 2 diabetic patients with or without nephropathy
  260. Reply to the Letter to the Editor “ADROPIN : Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease”
  261. Plasma ADROPIN levels in children with obstructive sleep apnea
  262. Plasma ADROPIN in exercised horses: a pilot study
  263. Diagnostic Value of ADROPIN Levels in Acute Pulmonary Embolism Patients
  264. ADROPIN Enhances Glucose Disposal and Cardiovascular Function in Rats (LB761)
  265. ADROPIN is involved in the protective effect of ellagic acid against high-glucose induced injury in human umbilical venous endothelial Cells
  266. Diagnostic efficiency of ADROPIN as a preliminary test to exclude acute pulmonary embolism: a prospective study
  267. Age-Dependent Decrease in ADROPIN is Associated with Reduced Levels of Endothelial Nitric Oxide Synthase and Increased Oxidative Stress in the Rat Brain
  268. Peripheral ADROPIN Application Regulates Nutritional Behavior and Fat Tissue-mediated Energy Metabolism
  269. Serum ADROPIN and Vaspin Levels in Obese Rats with Polycystic Ovary Syndrome and After Metformin Treatment
  270. THU0489 Enho Gene Expression and Serum ADROPIN Level in Rheumatoid Arthritis and Systemic Lupus Erythematosus
  271. A study on the effect of ADROPIN on blood pressure in male albino rats
  272. Association of serum ADROPIN with risk and severity of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
  273. Serum ADROPIN Level is Associated With Exercise Training-induced Improvement of Arterial Stiffness in Obese Adults
  274. GW29-e0390 Effect of ADROPIN on the onset and prognosis of acute myocardial infarction
  275. Soluble Vascular Adhesion Protein-1 Level Correlates With ADROPIN and Inflammatory Biomarkers in Patients With Obstructive Sleep Apnea
  276. N. Current Knowledge of Selected Cardiovascular Biomarkers in Pediatrics: Kidney Injury Molecule-1, Salusin-α and-β, Uromodulin, and ADROPIN
  277. Serum ADROPIN Level in Patients with Isolated Coronary Artery Ectasia
  278. ADROPIN is a Novel and Potent Endogenous Angiogenic Neuroendocrine Peptide
  279. ADROPIN expression correlates with aging-related neuropathology in the human brain and improves neuroinflammation and cognitive function in aging mice
  280. The relationship between radial artery spasm and ADROPIN levels in patients undergoing transradial coronary angiography
  281. ADROPIN , nesfatin-1 and angiotensin II receptor expression in the abdominal aorta in ovariectomized rats after nesfatin-1 treatment
  282. Role of ADROPIN in reducing arterial stiffness in type 2 diabetes
  283. The Effect Of A Period Of Aerobic Exercise With Low Intensity On ADROPIN Levels And Insulin Resistance Index In Obese Sedentary Adolescent Boys
  284. Possible Relation between Exercise, Nonalcoholic Fatty Liver Disease and ADROPIN
  285. ADROPIN Enhancement of Cardiac Insulin Sensitivity and Inhibition of Fatty Acid Oxidation are Associated With Improvement of Cardiac Function and Efficiency in …
  286. Effect of Short-Term Aerobic Exercise Training on ADROPIN Levels in Obese Rats.
  287. ASSOCIATION BETWEEN ADROPIN AND PULSE WAVE VELOCITY IN HYPERTENSIVE PATIENTS WITH DIABETES MELLITUS 2 TYPE
  288. Diagnostic Efficiency of ADROPIN As A Preliminary Test To Exclude Acute Pulmonary Embolism
  289. The relationship of plasma ADROPIN levels in pediatric obese patients with OSA
  290. Effects of vitamin D treatment on the heart tissue and ADROPIN levels in thyrotoxicosis rats
  291. Effect of serum ADROPIN level and cinnamon water extract on normal and alloxan-induced diabetic adult male albino rats
  292. Changes of serum ADROPIN , platelet activating factor and glial fibrillary acidic protein levels in patients with coronary heart disease complicating depression and their …
  293. THE INFLUENCE OF OBESITY ON INTERRELATION BETWEEN ADROPIN AND PULSE WAVE VELOCITY IN HYPERTENSIVE PATIENTS
  294. Study on correlation between ADROPIN protein and homocysteine level in patients with coronary artery disease
  295. ADROPIN and irisin: New biomarkers of cardiac status in patients with end-stage renal disease? A preliminary study
  296. Mesenteric adipose and intestinal tissue expression and serum level of ADROPIN in Crohn’s disease patients
  297. The effect of eight weeks combined exercise training on the levels of ADROPIN and VEGFR-2 in obese men with hypertension
  298. Effects of Cardiopulmonary Bypass Operation on Circulating Levels of ADROPIN , Elabela, and Nitric Oxide Depending on the Time Intervals
  299. A Novel Hypothalamic Action of ADROPIN : Regulation of Fluid Homeostasis
  300. Effect of Exercise Training and ADROPIN Treatment on Thyroid and Testicular Function Changes in Obese Type 2 Diabetic Rats.
  301. Comparing the Pancreatic and Pulmonary Protective Effects of ADROPIN and Dexamethasone on L-arginine Induced Acute Pancreatitis in Rats
  302. ADROPIN : An endocrine link between the biological clock and cholesterol homeostasis
  303. ASSOCIATIAON BETWEEN ADROPIN AND ATHEROSCLEROSIS IN HYPERTENSIVE PATIENTS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS AND …
  304. Loss of ADROPIN causes arterial stiffening in mouse femoral and mesenteric arteries
  305. A6607 The Effects of ADROPIN on the Myocardial Mitochondria injury in Rats with Metabolic Syndrome
  306. Total testosterone, adiponectin and ADROPIN in a group of men: Relation to age
  307. Vasodilatory Function in Human Skeletal Muscle Arteries with Advancing Age: Role of ADROPIN
  308. Effects of Eight Weeks of Resistance Training and High-Intensity Interval Training on ADROPIN , Blood Glucose Markers, Insulin Resistance, and Body Composition of …
  309. ADROPIN levels and target organ damage secondary to high blood pressure in emergency department
  310. ADROPIN acts in the paraventricular nucleus of the hypothalamus to influence neuronal excitability
  311. The study of ADROPIN and irisin in diagnostics of acute myocardial infarction with complex obesity and 2 type diabetes mellitus
  312. ADROPIN and Irisin Deficiencies Are Associated With Presence of Diagonal Earlobe Crease in CAD Patients
  313. GW26-e1596 Effects of atorvastatin on mRNA and protein expression of ADROPIN in cultured human umbilical endothelial cells and rat artery smooth muscle cells
  314. GW27-e1228 The combination of ADROPIN and ischemic postconditioning alleviates myocardial ischemia-reperfusion injury in aged diabetic mice
  315. P166Assessment of the relationship between novel proteins and cardiac cachexia in heart failure patients with reduced ejection fraction: ADROPIN and irisin
  316. The predictive value of serum S1P and ADROPIN levels for the restenosis after cerebrovascular stent implantation and their relationship with vasoactive …
  317. Developmental regulation of obestatin and ADROPIN in Prader-Willi syndrome and non-syndromic obesity: associations with weight, BMI-z, HOMA-IR, and lipid …
  318. Search for early markers of gestational diabetes mellitus–comparison of first and third trimester levels of ADROPIN , copeptin and vitamin D in prediction of perinatal …
  319. Characterization of novel peptide hormones and elucidation of their cognate receptors: ADROPIN & phoenixin
  320. Changes in serum ADROPIN , salusin alpha and salusin beta, vaspin, and preptin in hyperemesis gravidarum
  321. PS 02-75 ANALYSIS OF SERUM ADROPIN IN HYPERTENSION WITH ACUTE CORONARY SYNDROME
  322. IL-18 AND ADROPIN LEVELS IN PATIENTS WITH ACUTE ISCHEMIC STROKE
  323. OP-059 The Relationship between ADROPIN Levels and the Slow Coronary Flow Phenomenon
  324. Comparison of Serum Netrin-1. Nesfatin-1 and ADROPIN Levels in Subclinical and Overt Hypothyroidism

Related Posts

Shopping Cart
Scroll to Top